Mastery EAQ Ch. 30

A  Octreotide

B  Corticotropin

C  Desmopressin

D  Somatropin

A  Vasopressin

B  Desmopressin

C  Somatropin

D  Octreotide

A  “You should consult your primary health care provider immediately.”

B  “Skip the missed dose and resume your usual dosage schedule.”

C  “You can take the dose immediately when you remember it.”

D  “If it is almost time for your next dose, take a double dose of the drug at that time.”

A  Cosyntropin

B  Somatropin

C  Desmopressin

D  Vasopressin

A  Drowsiness

B  Vertigo

C  Abdominal stress

D  Bleeding gums

A  “Keep the bottle in warm water before administration.”

B  “Heat the medicine before administration.”

C  “Do not administer the drug to the patient.”

D  “Shake the medication before administration.”

A  Monitor fluid status.

B  Monitor blood glucose levels closely.

C  Evaluate the patient for limping.

D  Encourage vigorous exercise.

A  Administering the vasopressin intravenously

B  Obtaining liver and renal function tests

C  Monitoring the patient in an intensive care unit

D  Co-administering carbamazepine

A  Excessive thirst

B  Bleeding gums

C  Abdominal cramps

D  Limping

A  Nausea, Blood glucose elevation, Headache, Low urine output

B  Headache, Low urine output, Low blood pressure, Nausea

C  Nausea, Blood glucose elevation, Headache, Low blood pressure

D  Low blood pressure, Blood glucose elevation, Headache, Low urine output

A  Somatropin intramuscular

B  Octreotide subcutaneous

C  Desmopressin intravenously

D  Vasopressin nasal spray

A  Blood glucose

B  Renal panel

C  Electrocardiogram (ECG)

D  Liver enzymes

A  Reports episodic muscle pain during the past year.

B  Previous somatropin injection site tender to touch.

C  Radiology report identifies no fracture with closed growth plates.

D  Growth percentile has increased from the previous annual physical.

A  Obtain baseline weight and height measurements

B  Review current laboratory values for blood glucose

C  Calculate the dosage with the pharmacist or another nurse

D  Review the frequency with the health care provider

A  Monitor for signs of infiltration

B  Notice increase in body temperature

C  Inquire about abdominal discomfort

D  Assess the patient for headaches

A  Weight gain, Edema of the extremities

B  Edema of the extremities, Elevated blood pressure

C  Elevated blood pressure, Weight gain

D  Increased urination, Thirst

A  Assess for signs of dehydration.

B  Measure the patient’s urine output regularly.

C  Watch the IV site closely for infiltration.

D  Make a note of the fluid intake.

A  Esophageal varices and a history of type 2 diabetes

B  Acromegaly and a serum creatinine level of 5.0 mg/dL

C  Small-bowel fistula and having an acute asthma attack

D  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

C  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

D  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

A  Patient D: VIP; severe diarrhea and flushing; renal impairment

B  Patient B: carcinoid tumor; taking ciprofloxacin

C  Patient A: esophageal varices; type 1 diabetes

D  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

A  Joint pain, Fatigue

B  Fatigue, Headache

C  Headache, Joint pain

D  Diarrhea, Flushing

A  A higher dose of medication is required for treatment.

B  The medication is not effective for this condition.

C  The patient needs to adjust fluid intake.

D  The patient is stable and needs reassurance.

A  Storing the pump at room temperature

B  Priming the pump each week

C  Inhaling the medication into the airway

D  Administering half the dose in each nostril

A  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

B  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

C  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

D  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

A  Height, Weight, Motor skills

B  Motor skills, Visual acuity, Skin turgor

C  Weight, Skin turgor, Visual acuity

D  Skin turgor, Height, Visual acuity

A  Pressing the pump once to spray a 10-mcg dose

B  Priming the nasal pump once a week

C  Replacing the cap on the pump after the procedure

D  Pressing down on the pump two times to prime it

A  Hypertension

B  Hypothyroidism

C  Hypercalciuria

D  Hyperglycemia

A  “Apply the drug preparation topically to the nasal membranes.”

B  “Shake the drug preparation thoroughly before use.”

C  “Inhale the drug preparation by spraying into the nostrils.”

D  “Dilute the drug preparation before administration.”

A  Abundant, diluted urine

B  Oozing blood

C  Loss of consciousness

D  Watery diarrhea

A  Bilateral metastatic breast cancer

B  Cachexia and closed growth plates

C  Acute bronchitis with laryngitis

D  Human immunodeficiency virus (HIV) infection

A  A 17-year-old who is 5 feet tall

B  A 10-year-old of short stature who has severe asthma

C  A 7-year-old diagnosed with growth hormone deficiency

D  An 8-year-old with a pituitary tumor

A  Desmopressin and carbamazepine

B  Vasopressin and demeclocycline

C  Vasopressin and carbamazepine

D  Somatropin and glucocorticoids

A  Seizures

B  Hypoglycemia

C  Heartburn

D  Edema

A  Orthostatic hypotension

B  Hypokalemia

C  Hyponatremia

D  Hyperglycemia

A  Cyclosporine

B  Fludrocortisone

C  Ciprofloxacin

D  Glucocorticoids

A  Asthma, Diabetes insipidus, Type I von Willebrand

B  Diabetes insipidus, Seizure, Type I von Willebrand

C  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

D  Seizure, Asthma, Cardiovascular disease

A  Decreases growth

B  Reduces fat levels

C  Decreases fluid retention

D  Reduces weight loss

A  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

B  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

C  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

D  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

A  Acetaminophen

B  Thioridazine

C  Carbamazepine

D  Norepinephrine

A  Renal function studies, Liver enzyme levels, Blood pressure

B  Weight, Blood pressure, Blood glucose levels

C  Liver enzyme levels, Blood glucose levels, Renal function studies

D  Liver enzyme levels, Renal function studies, Weight

A  Arthralgia, Hypercalciuria, Constipation

B  Malaise, Dyspnea,

C  Dyspnea, Constipation, Hypercalciuria

D  Constipation, Malaise, Hypercalciuria

A  Edema

B  Inflammation

C  Scar formation

D  Hypotension

A  Reduces the effects of desmopressin

B  Produces an additive effect

C  Causes prolongation of QT interval

D  Enhances the effects of desmopressin

A  Octreotide

B  Desmopressin

C  Vasopressin

D  Somatropin

A  Octreotide

B  Cosyntropin

C  Desmopressin

D  Somatropin

A  Dehydration

B  Headache

C  Polyuria

D  Polydipsia

A  Thyroid hormone

B  Cosyntropin

C  Oxytocin

D  Octreotide

A  Cyclosporine

B  Ciprofloxacin

C  Carbamazepine

D  Demeclocycline

A  Creatinine clearance test

B  Complete blood count result

C  Uric acid level

D  Blood glucose level

A  Vasopressin

B  Desmopressin

C  Luteinizing hormone

D  Somatropin

A  Polyuria

B  Acromegaly

C  Polydipsia

D  Hypopituitary dwarfism

A  Oxytocin

B  Octreotide

C  Vasopressin

D  Cosyntropin

A  Choriomammotropin

B  Somatolactin

C  Somatostatin

D  Somatropin

A  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

B  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

D  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

A  Increased urine specific gravity

B  Relief of pain

C  Decreased adrenocorticotropic hormone levels

D  Increased serum albumin levels